Related Experiment Video
Updated: Jun 12, 2026
10:02
Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Big Data in Pediatric Oncology: Hope, Hype, Reality
Kirk D Wyatt1, Samuel L Volchenboum2
1Department of Pediatric Hematology/Oncology, Roger Maris Cancer Center, Sanford Health, 820 4th Street North, Fargo, ND 58102, USA.
Hematology/Oncology Clinics of North America
|June 10, 2026
Summary
Big data approaches offer revolutionary potential in pediatric oncology for improving patient health. However, significant challenges must be addressed to fully leverage these big data methods in cancer research.
Area of Science:
- Oncology
- Biomedical Informatics
- Data Science
Background:
- The application of big data in medicine, particularly pediatric oncology, is rapidly expanding.
- Big data approaches promise to transform the collection, analysis, and utilization of biomedical information.
Purpose of the Study:
- To explore the applications of big data in pediatric oncology.
- To identify challenges hindering the effective use of big data in this field.
- To discuss potential solutions and future directions for big data utilization.
Main Methods:
- Review of current big data applications in pediatric oncology.
- Analysis of limitations and challenges in existing big data methodologies.
- Exploration of promising future strategies for big data implementation.
Main Results:
- Growing interest and proposed uses of big data in pediatric oncology.
- Identification of distinct challenges that limit the full potential of big data in improving health outcomes.
- Discussion of innovative approaches to overcome these limitations.
Conclusions:
- Big data holds significant promise for advancing pediatric oncology care and research.
- Addressing current challenges is crucial for harnessing the full benefits of big data.
- Further research and development of novel methods are needed to optimize big data utilization.
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...